Royal Bank Of Canada Purple Biotech Ltd. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.58 - $0.92 $1,247 - $1,978	2,150 Added 26875.0%	2,158 $1,000
Q4 2023 Feb 14, 2024	SELL	$0.78 - $1.67 $78 - $167	-100 Reduced 92.59%	8 $0
Q1 2022 May 16, 2022	BUY	$2.45 - $4.3 $264 - $464	108 New	108 $0

19.3K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $46.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.